EMPAZA Trademark
Trademark Overview
On Monday, November 19, 2001, a trademark application was filed for EMPAZA with the United States Patent and Trademark Office. The USPTO has given the EMPAZA trademark a serial number of 76340777. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Wednesday, December 4, 2002. This trademark is owned by Pfizer Inc.. The EMPAZA trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, obesity, inflammation and inflammatory diseases, respiratory and infectious diseases and immunological, bacterial, viral and fungal disorders; pharmaceutical preparations, namely, cholesterol reducers, smoking cessation preparations, tissue and skin repair preparations, dermatological preparations and preparations for the treatment of gynecological disorders
General Information
| Serial Number | 76340777 |
| Word Mark | EMPAZA |
| Filing Date | Monday, November 19, 2001 |
| Status | 605 - ABANDONED - EXPRESS AFTER PUB |
| Status Date | Wednesday, December 4, 2002 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, July 9, 2002 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, obesity, inflammation and inflammatory diseases, respiratory and infectious diseases and immunological, bacterial, viral and fungal disorders; pharmaceutical preparations, namely, cholesterol reducers, smoking cessation preparations, tissue and skin repair preparations, dermatological preparations and preparations for the treatment of gynecological disorders |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 8 - Abandoned |
| Class Status Date | Wednesday, December 4, 2002 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Pfizer Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10017 |
| Party Name | Pfizer Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10017 |
Trademark Events
| Event Date | Event Description |
| Wednesday, December 4, 2002 | ABANDONMENT - AFTER PUBLICATION |
| Tuesday, November 26, 2002 | OPPOSITION TERMINATED NO. 999999 |
| Tuesday, November 26, 2002 | OPPOSITION INSTITUTED NO. 999999 |
| Monday, August 12, 2002 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| Tuesday, July 9, 2002 | PUBLISHED FOR OPPOSITION |
| Wednesday, June 19, 2002 | NOTICE OF PUBLICATION |
| Tuesday, February 26, 2002 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, February 19, 2002 | EXAMINER'S AMENDMENT MAILED |
| Thursday, February 7, 2002 | ASSIGNED TO EXAMINER |
| Tuesday, February 5, 2002 | ASSIGNED TO EXAMINER |
